You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 8, August 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Single-Dose Antibiotic Prophylaxis for Biliary Surgery

Cefazolin vs Moxalactam

John M. Kellum, MD; Richard J. Duma, MD, PhD; Sherwood L. Gorbach, MD; Harvey J. Sugerman, MD; Boyd W. Haynes, Jr, MD; Alfred Gervin, MD; Heber H. Newsome, MD

Arch Surg. 1987;122(8):918-922.


Abstract

• Cefazolin was compared with moxalactam for single-dose prophylaxis against infection in a double-blind, prospective, randomized trial of 90 patients undergoing cholecystectomy. Risk factors for infection were present in 65 (72%) of the 90 patients and were evenly distributed. Antibiotic levels in plasma, bile, and tissue measured when the cystic duct was divided were similar for both drugs. Age greater than 65 years but not recent cholecystitis or type of antibiotic was predictive of recovery of bacteria from bile cultures. Wound infections occurred in two patients receiving cefazolin and one patient receiving moxalactam for an overall infection rate of 3%. No toxic reactions to antibiotics, including bleeding disorders, were observed. In conclusion, no significant difference in prophylactic efficacy was detected in this comparison of a first-generation with a third-generation cephalosporin. Because of its lower cost and narrower antimicrobial spectrum, however, cefazolin should remain the agent of choice.

(Arch Surg 1987;122:918-922)



Author Affiliations

From the Departments of Surgery (Drs Kellum, Sugerman, Haynes, Gervin, and Newsome) and Medicine (Dr Duma), The Medical College of Virginia, Virginia Commonwealth University, Richmond; and the Department of Medicine (Dr Gorbach), Tufts University School of Medicine, Boston.


Footnotes

Accepted for publication July 18, 1986.

Reprint requests to MCV Station, Box 161, Richmond, VA 23298 (Dr Kellum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prophylactic Antibiotics for Elective Laparoscopic Cholecystectomy: Are They Necessary?
Higgins et al.
Arch Surg 1999;134:611-614.
ABSTRACT | FULL TEXT  

Postoperative T-Tube Cholangiography: Is Routine Antibiotic Prophylaxis Necessary? A Prospective, Controlled Study
Sheen-Chen et al.
Arch Surg 1995;130:20-23.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.